Chat with us, powered by LiveChat

Loading...

Lipids Active Pharmaceutical Ingredient Market Report

RA00380

Lipids Active Pharmaceutical Ingredient Market, by Type (Simple Lipids, Compound Lipids, Derived Lipids), Application (Cardiovascular Disease, Inflammatory Diseases, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027

RA00380

Pages: NA

Jun 2020

COVID-19

pandemic has shown to have an enormous impact on most
industries.

Click Here to access our comprehensive analysis of the

Impact of covid-19 on Lipids Active Pharmaceutical Ingredient Market

Global Lipids Active Pharmaceutical Ingredient Market Analysis:

Lipids are fatty acids in nature and include multiple soluble vitamins (like vitamins A, D, E, and K), waxes, glycerides, steroids, phospholipids, and natural oils which are beneficial to the human body. They can be utilized for multiple medicinal purposes. Further, lipids active pharmaceutical ingredients refer to the organic compounds that are used as active ingredients in any drug and provide medicinal properties. They possess the capacity to treat, cure, or improve health in multiple disorders like cancer, cardiovascular diseases, and others. Owing to these benefits, the demand for lipids active pharmaceutical ingredients is increasing in the global healthcare industry.

Increasing neurological diseases, rising prevalence of cardiovascular disorders, rising cancer, and chronic diseases patients to drive the market growth

Neurological disorders such as Alzheimer's disease, dementia, epilepsy, stroke, sclerosis, migraine, Parkinson’s disease, and brain tumors are majorly increasing across the globe. Due to the growing occurrence of these diseases, it has become extremely vital to develop and provide appropriate medicines for their treatment. Lipids active pharmaceutical ingredients provide vital medicinal effects to these patients and help in the healing process owing to which their usage and incorporation in drugs have increased aggressively benefiting the market. Further, according to an updated report from the World Health Organization (WHO), more than 17 million people die annually due to cardiovascular diseases, making it the number one cause of deaths worldwide. Cardiovascular diseases have increased massively owing to improper lifestyle, negative habits, and no physical activities. This has caused a massive strain on the healthcare sector to opt for better medication to save as many people as possible dying from cardiovascular diseases. According to WHO, if the changes aren’t made in the healthcare sector and lifestyle soon then the annual figure of death by cardiovascular diseases could reach up to 23.6 million by the year 2030. These figures have made it necessary to incorporate better medicinal ingredients which enhance the healing process, due to which the demand for lipids active pharmaceutical ingredients has massively increased. Owing to all these factors the demand for lipids active pharmaceutical ingredients will increase majorly and will drive the market growth.

Stringent quality standards and patent expirations to hamper the market growth

Stringent quality standards by various governments across the globe have significantly affected the market growth as manufacturers of lipids active pharmaceutical ingredients can’t improve the process design. These quality standards negatively impact the profitability of manufacturers as well as increase time and development costs. Some of these standards are GMP (Good Manufacturing Practices), ICH (International Conference on Harmonization), and cGMP (current GMP). Further, patent expirations have posed a great threat to revenue growth. All these factors are hindering the smooth supply of lipids active pharmaceutical ingredients on a wider and larger basis across the globe.

Increased awareness and adoption, growing demand for effective and fast-acting drugs, healthcare infrastructural development to create lucrative market opportunities

Growing awareness amongst the healthcare industry about the healing and curing benefits offered by lipids active pharmaceutical ingredients has positive effects on their adoption across the globe. Major research & development activities are being conducted by multiple organizations, companies, educational institutions to further enhance their effects when consumed by a patient to improve the treatment process. This has led to the wide adoption of lipids active pharmaceutical ingredients in various medicinal drugs and offered lucrative opportunities for market growth. Furthermore, growing demand for effective and fast-acting drugs by healthcare industries for the treatment of various health ailments like cancer, cardiovascular diseases, and others has also created major opportunities for growth. Also, the ongoing development of advanced and better drug production facilities has enabled manufacturers to produce lipids active pharmaceutical ingredients in large quantities. Owing to increased production their usage will increase for multiple purposes.

Global Lipids Active Pharmaceutical Ingredient Market, by Type:

Simple lipids segment will be the most lucrative till 2027

Simple lipids segment will have a dominating share in the global market and they are expected to register a significant revenue during the forecast period. They play an important role in cells, such as energy storage (oils and fats) and supply, acts as a carrier of electrons/oxygen, balances hormones, and is a constituent of membranes. They provide multiple healing benefits and have wide applications in the healthcare industry. Owing to all these benefits the demand for simple lipids is growing majorly.

Global Lipids Active Pharmaceutical Ingredient Market, by Application:

Cardiovascular diseases segment to register maximum growth

The cardiovascular disease segment is anticipated to register maximum growth in lipids active pharmaceutical ingredients market during the forecast period. Rising cardiovascular patients and increased adoption by the healthcare industry of drug manufacturing for cardiovascular diseases are the major factors driving the market growth. Furthermore, growing research & development activities and rising investments in healthcare infrastructure have facilitated major incorporation of lipids active pharmaceutical ingredients in medicines. Due to all these factors, the cardiovascular disease application will be the most lucrative for lipids active pharmaceutical ingredients market.

Global Lipids Active Pharmaceutical Ingredient Market, by Region:

Asia-Pacific region to hold the largest market share

Asia-Pacific region is expected to hold the largest share in the lipids active pharmaceutical ingredients market during the forecast timeframe. Asia-Pacific region is the fastest-growing economy, majorly investing in research & development activities to develop better drugs. In addition, growing cancer patients, cardiovascular diseases, and neurological disorders particularly in China, India, and Japan have led to massive incorporation of lipids active pharmaceutical ingredients in medicine production. Further, the major availability of active pharmaceutical manufacturers is also facilitating market growth, in the APAC region.

Key Participants in the Global Lipids Active Pharmaceutical Ingredient Market:

Merger & acquisition and advanced product development are the frequent strategies followed by the market players

Key Participants in the Global Lipids Active Pharmaceutical Ingredient Market

Source: Research Dive Analysis

Some of the significant global lipids active pharmaceutical ingredient market players include Sancilio & Company, Inc., Cerbios-Pharma SA, CordenPharma International, Merck KGaA, VAV Life Sciences, Avanti Polar Lipids., DSM Nutritional Products AG, Cayman Chemical, ESPERION Therapeutics, Inc., and ABITEC.

Global lipids active pharmaceutical ingredient market players are emphasizing more on merger & acquisition and advanced product development. These are the frequent strategies followed by established organizations. To emphasize more on the competitor analysis of market players, Porter’s five forces model is explained in the report.

Aspect

Particulars

 Historical Market Estimations

 2018-2019

 Base Year for Market Estimation

 2018

 Forecast timeline for Market Projection

 2020-2027

 Geographical Scope

 North America, Europe, Asia-Pacific, LAMEA

 Segmentation by Type

  • Simple Lipids
  • Compound Lipids
  • Derived Lipids

 Segmentation by Application

  • Cardiovascular Disease
  • Inflammatory Diseases
  • Others

 Key Countries Covered

U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

 Key Companies Profiled

  • Sancilio & Company, Inc.
  • Cerbios-Pharma SA
  • CordenPharma International
  • Merck KGaA
  • ESPERION Therapeutics, Inc.
  • VAV Life Sciences
  • Avanti Polar Lipids.
  • DSM Nutritional Products AG
  • Cayman Chemical
  • ABITEC

FREQUENTLY ASKED QUESTIONS?
 

A. Merck KGaA, CordenPharma International, and Avanti Polar Lipids. are the leading companies in the global lipids active pharmaceutical ingredient market.

A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.

A. Technological advancements, product development, along with joint ventures are the key strategies opted by the operating companies in this market.

A. ABITEC and Merch KGaA are investing more in R&D practices.

Research Methodology

Purchase Options

Enquire To Buy

Personalize this research

  • Triangulate with your own data
  • Get Data as per your format and defination
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

RELATED TAGS

Lipids Active Pharmaceutical Ingredient Market

Customers Also Viewed